A randomised, double-blind, placebo-controlled, parallel-group, 52 week study to evaluate the efficacy and safety of oral DHEA therapy in postmenopausal women of sexual function wellbeing and vasomoto

  • Davis, Susan (Primary Chief Investigator (PCI))
  • Bell, Robin (Chief Investigator (CI))
  • Panjari, Mary, (Chief Investigator (CI))
  • Papalia, Mary-Anne, (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date10/11/069/11/07